The story of Viagra and its influence on the healthcare landscape presents a thorny question for shareholders . Initially a blockbuster drug, competitors have significantly eroded its market presence , creating difficulties for companies connected to the original patent holder and subsequent formulas. While certain firms might benefit from speciali